Progress in Retinal and Eye Research最新文献

筛选
英文 中文
Macular fibrosis secondary to neovascular age-related macular degeneration: from clinic to biology 新生血管性年龄相关性黄斑变性继发黄斑纤维化:从临床到生物学。
IF 16.2 1区 医学
Progress in Retinal and Eye Research Pub Date : 2026-07-01 Epub Date: 2026-06-07 DOI: 10.1016/j.preteyeres.2026.101488
Heping Xu, Jiaxin Pu, Caijiao Yi, Wen Deng, Xiang-Ling Yuan, Zhongping Chen, Qian Xiang, Qichang Wang, Feng Wen, Mei Chen
{"title":"Macular fibrosis secondary to neovascular age-related macular degeneration: from clinic to biology","authors":"Heping Xu,&nbsp;Jiaxin Pu,&nbsp;Caijiao Yi,&nbsp;Wen Deng,&nbsp;Xiang-Ling Yuan,&nbsp;Zhongping Chen,&nbsp;Qian Xiang,&nbsp;Qichang Wang,&nbsp;Feng Wen,&nbsp;Mei Chen","doi":"10.1016/j.preteyeres.2026.101488","DOIUrl":"10.1016/j.preteyeres.2026.101488","url":null,"abstract":"<div><div>Macular subretinal fibrosis represents the end-stage complication of neovascular age-related macular degeneration (nAMD). Despite the widespread use of anti-VEGF therapy, between 20 and 67% of nAMD patients develop this sight-threatening condition within 2 to 7 years, making fibrosis one of the main reasons responsible for anti-VEGF resistance and irreversible visual loss. Unlike the quiescent scar of a healed skin wound, subretinal fibrosis is a dynamic, vascularised lesion characterised by persistent and active inflammation, a process aptly termed “hot fibrosis”. The molecular mechanisms that drive the conversion of neovascularisation into fibrovascular membrane remain poorly defined. This review summarises the clinical features of macular fibrosis in nAMD. It will then detail the pathological insights gained from advanced clinical high-resolution imaging and post-mortem histopathological investigations. We will also explore how advances in our understanding of the pathogenesis of macular fibrosis, as revealed by preclinical models, are uncovering novel therapeutic targets. Promising approaches include dual-targeting agents (e.g., inhibiting VEGF and Ang-2 or complement pathways), as well as repurposing FDA-approved anti-fibrotics, such as pirfenidone or nintedanib, for ocular delivery. The repurposing of drugs with established safety profiles, reformulated for local intraocular use, offers a particularly resource-efficient pathway.</div></div>","PeriodicalId":21159,"journal":{"name":"Progress in Retinal and Eye Research","volume":"113 ","pages":"Article 101488"},"PeriodicalIF":16.2,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148205996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Visual arrestin-1: how did we learn what we know today about this protein? 视觉阻滞-1:我们今天是如何了解这种蛋白质的?
IF 16.2 1区 医学
Progress in Retinal and Eye Research Pub Date : 2026-07-01 Epub Date: 2026-07-03 DOI: 10.1016/j.preteyeres.2026.101491
Vsevolod V. Gurevich, Eugenia V. Gurevich
{"title":"Visual arrestin-1: how did we learn what we know today about this protein?","authors":"Vsevolod V. Gurevich,&nbsp;Eugenia V. Gurevich","doi":"10.1016/j.preteyeres.2026.101491","DOIUrl":"10.1016/j.preteyeres.2026.101491","url":null,"abstract":"<div><div>Proteins are studied using a wide variety of methods, each with its inherent limitations. Here we analyze the contributions of different methods to our understanding of one of the most extensively studied proteins, arrestin-1, which plays a key role in the regulation of light-evoked signaling of photopigments in the photoreceptor cells in the retina. The data obtained by biochemical and biophysical methods <em>in vitro</em> are consistent with the results of <em>in vivo</em> studies in genetically modified mice and the symptoms seen in human patients. The structures of free arrestin-1 and its complex with rhodopsin provided very detailed information and stimulated structure-function studies. However, while the results of follow-up experiments confirmed some predictions from the crystal structures, they were inconsistent with others. In particular, the arrestin-1 tetramer in solution and in the photoreceptors of living mice was shown to be dramatically different from that revealed by the crystal structures. The prevalent complex (es) of wild type arrestin-1 with rhodopsin also appear to differ from the one in the solved structure of the two interacting mutant proteins. The lessons learned with arrestin-1 likely also apply to other proteins.</div></div>","PeriodicalId":21159,"journal":{"name":"Progress in Retinal and Eye Research","volume":"113 ","pages":"Article 101491"},"PeriodicalIF":16.2,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148382451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcending genome-wide association studies to create useful multi-omic views of glaucoma 超越全基因组关联研究,创建青光眼有用的多组学观点。
IF 16.2 1区 医学
Progress in Retinal and Eye Research Pub Date : 2026-07-01 Epub Date: 2026-07-02 DOI: 10.1016/j.preteyeres.2026.101490
Keva Li, Jae Hee Kang, Anthony P. Khawaja, Sandra Jardines, Joëlle Vergroesen, Wishal Ramdas, Kelsey Stuart, Robert Luben, Pirro Hysi, Akiko Hanyuda, Oana Zeleznik, Ayellet V. Segrè, Neeru Amrita Vallabh, Ya Yuan Rachel Leung, Janey L. Wiggs, Louis R. Pasquale
{"title":"Transcending genome-wide association studies to create useful multi-omic views of glaucoma","authors":"Keva Li,&nbsp;Jae Hee Kang,&nbsp;Anthony P. Khawaja,&nbsp;Sandra Jardines,&nbsp;Joëlle Vergroesen,&nbsp;Wishal Ramdas,&nbsp;Kelsey Stuart,&nbsp;Robert Luben,&nbsp;Pirro Hysi,&nbsp;Akiko Hanyuda,&nbsp;Oana Zeleznik,&nbsp;Ayellet V. Segrè,&nbsp;Neeru Amrita Vallabh,&nbsp;Ya Yuan Rachel Leung,&nbsp;Janey L. Wiggs,&nbsp;Louis R. Pasquale","doi":"10.1016/j.preteyeres.2026.101490","DOIUrl":"10.1016/j.preteyeres.2026.101490","url":null,"abstract":"<div><div>Glaucoma is a leading cause of irreversible blindness worldwide, characterized by progressive retinal ganglion cell loss and functional impairment. It is a clinically heterogeneous disease driven by complex, multilayered molecular mechanisms. High-throughput multi-omic technologies are catalyzing a shift toward integrated multi-omic strategies to define glaucoma trajectory and disentangle its pathophysiology. Genomic, transcriptomic, epigenomic, proteomic, metabolomic, lipidomic, microbiome, and phenomic data can help identify biomarkers, molecular endotypes, and pathways that shape glaucoma susceptibility and progression. In this review, we synthesize the current multi-omic landscape in glaucoma, evaluate the strengths and limitations of each modality, and highlight key challenges in integrative approaches. Lastly, we propose conceptual and methodological frameworks for leveraging multi-omics to define the full spectrum of glaucoma, with a focus on optic nerve integrity, mechanistic insights, and precision medicine, while remaining agnostic to evolving omics technologies.</div></div>","PeriodicalId":21159,"journal":{"name":"Progress in Retinal and Eye Research","volume":"113 ","pages":"Article 101490"},"PeriodicalIF":16.2,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148376829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cutting-edge cross-linking biomaterials advancing ophthalmic therapeutics 尖端交联生物材料推进眼科治疗。
IF 16.2 1区 医学
Progress in Retinal and Eye Research Pub Date : 2026-07-01 Epub Date: 2026-06-19 DOI: 10.1016/j.preteyeres.2026.101489
Rui Ning, Xueyu Fu, Lingxin Chen, Haochen Liu, Xiaomin Huang, Zhongxing Chen, Yi Shao, Keith M. Meek, Farhad Hafezi, Mark Hillen, Wei Tao, Xingtao Zhou, Mei Yang, Jinhai Huang
{"title":"Cutting-edge cross-linking biomaterials advancing ophthalmic therapeutics","authors":"Rui Ning,&nbsp;Xueyu Fu,&nbsp;Lingxin Chen,&nbsp;Haochen Liu,&nbsp;Xiaomin Huang,&nbsp;Zhongxing Chen,&nbsp;Yi Shao,&nbsp;Keith M. Meek,&nbsp;Farhad Hafezi,&nbsp;Mark Hillen,&nbsp;Wei Tao,&nbsp;Xingtao Zhou,&nbsp;Mei Yang,&nbsp;Jinhai Huang","doi":"10.1016/j.preteyeres.2026.101489","DOIUrl":"10.1016/j.preteyeres.2026.101489","url":null,"abstract":"<div><div>Corneal cross-linking (CXL) has emerged as an important therapeutic strategy for enhancing the biomechanical stability of corneal tissues. Originally introduced to slow or halt the progression of keratoconus (KC), its indications have expanded to include a variety of corneal ectatic and infectious disorders, alongside a growing interest in scleral reinforcement for progressive myopia. Recent advances in cross-linking technologies focused on optimizing reagent formulations, refining delivery strategies, and incorporating functional biomaterials such as nanoparticles, hydrogels, and microneedle-based systems to enhance stromal penetration, achieve controlled release, and reduce procedural invasiveness. Despite these developments, key challenges remain, particularly in achieving consistent treatment depth, maintaining long-term biosafety, and ensuring stable clinical outcomes. This review summarizes the mechanisms of action and classification of contemporary ophthalmic cross-linking methods and agents, evaluating their clinical and experimental outcomes in corneal and scleral cross-linking while weighing their respective strengths and limitations. Furthermore, this review identifies key constraints of current protocols and highlights emerging strategies aimed at improving treatment precision, safety, and reproducibility, thereby providing a conceptual framework for the development of next-generation ophthalmic cross-linking therapies.</div></div>","PeriodicalId":21159,"journal":{"name":"Progress in Retinal and Eye Research","volume":"113 ","pages":"Article 101489"},"PeriodicalIF":16.2,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148284148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minimally invasive glaucoma surgery in the surgical landscape of primary angle closure glaucoma: Current innovations and future trends 微创青光眼手术在原发性闭角型青光眼的外科视野:当前的创新和未来的趋势。
IF 14.7 1区 医学
Progress in Retinal and Eye Research Pub Date : 2026-05-01 Epub Date: 2026-04-24 DOI: 10.1016/j.preteyeres.2026.101470
Fei Li , Fengbin Lin , Zefeng Yang , Fengqi Zhou , Yunhe Song , Clement C. Tham , Ki Ho Park , Tin Aung , Tanuj Dada , Robert N. Weinreb , Dennis S.C. Lam , Xiulan Zhang
{"title":"Minimally invasive glaucoma surgery in the surgical landscape of primary angle closure glaucoma: Current innovations and future trends","authors":"Fei Li ,&nbsp;Fengbin Lin ,&nbsp;Zefeng Yang ,&nbsp;Fengqi Zhou ,&nbsp;Yunhe Song ,&nbsp;Clement C. Tham ,&nbsp;Ki Ho Park ,&nbsp;Tin Aung ,&nbsp;Tanuj Dada ,&nbsp;Robert N. Weinreb ,&nbsp;Dennis S.C. Lam ,&nbsp;Xiulan Zhang","doi":"10.1016/j.preteyeres.2026.101470","DOIUrl":"10.1016/j.preteyeres.2026.101470","url":null,"abstract":"<div><div>Primary angle-closure glaucoma (PACG) is a major cause of irreversible blindness worldwide, with the highest burden in Asia. Its pathogenesis involves the interplay of multiple mechanisms, including pupillary block, plateau iris configuration, lens-related crowding, and dynamic choroidal expansion. Traditional surgical management has relied on trabeculectomy, lens extraction, or transscleral cyclophotocoagulation, which often achieve substantial intraocular pressure (IOP) control but carry significant risks and require prolonged recovery.</div><div>Minimally invasive glaucoma surgery (MIGS) expands treatment options for PACG once angle access is restored. It offers safer, earlier, and targeted interventions tailored to the underlying mechanisms. Techniques range from trabecular meshwork (TM) and Schlemm's canal–based procedures to subconjunctival stents and ciliary body approaches. Combined with lens extraction, these methods deepen the anterior chamber, release peripheral anterior synechiae, and restore physiological outflow, with clinical evidence showing 20-50% IOP reductions and reduced medication burden.</div><div>This paper reviews anatomical, physiological, and clinical evidence for the use of MIGS in PACG, discussing how these procedures can complement, or in selected cases replace, invasive filtration surgery, potentially enabling earlier intervention while maintaining a favorable safety profile. Future advancements will hinge on device refinements for narrow-angle eyes, imaging-guided precision, biologic modulation, and strategies to enhance cost-effectiveness and accessibility, ultimately enabling individualized, mechanism-based treatment pathways.</div></div>","PeriodicalId":21159,"journal":{"name":"Progress in Retinal and Eye Research","volume":"112 ","pages":"Article 101470"},"PeriodicalIF":14.7,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147779731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retinal vessel imaging in inflammatory disease: From endothelial dysfunction to clinical evidence and translation 炎症性疾病的视网膜血管成像:从内皮功能障碍到临床证据和翻译。
IF 14.7 1区 医学
Progress in Retinal and Eye Research Pub Date : 2026-05-01 Epub Date: 2026-05-02 DOI: 10.1016/j.preteyeres.2026.101472
Timon Wallraven , Roman Günthner , Andrea Ribeiro , Momin Alnemer , Konstantin Kotliar , Maciej Lech , Nathalie Bleidißel , Rebecca Wicklein , Christoph Hauser , Lukas Streese , Martin J. Menten , Henner Hanssen , Christoph Schmaderer
{"title":"Retinal vessel imaging in inflammatory disease: From endothelial dysfunction to clinical evidence and translation","authors":"Timon Wallraven ,&nbsp;Roman Günthner ,&nbsp;Andrea Ribeiro ,&nbsp;Momin Alnemer ,&nbsp;Konstantin Kotliar ,&nbsp;Maciej Lech ,&nbsp;Nathalie Bleidißel ,&nbsp;Rebecca Wicklein ,&nbsp;Christoph Hauser ,&nbsp;Lukas Streese ,&nbsp;Martin J. Menten ,&nbsp;Henner Hanssen ,&nbsp;Christoph Schmaderer","doi":"10.1016/j.preteyeres.2026.101472","DOIUrl":"10.1016/j.preteyeres.2026.101472","url":null,"abstract":"<div><div>Inflammatory processes drive a heterogeneous spectrum of diseases, including cardiovascular (CV), neurodegenerative, autoimmune, rare, and viral disorders, which together account for a major global disease burden. Despite diverse clinical manifestations, these conditions share systemic endothelial dysfunction (ED) as a common pathophysiological hallmark. The retina, accessible through non-invasive imaging, provides a unique window into systemic microvascular health.</div><div>Over the past decades, retinal vessel analysis (RVA), both static and dynamic, has emerged as a robust tool for detecting and predicting microvascular alterations in inflammatory diseases. Large population-based cohorts, including the Atherosclerosis Risk in Communities (ARIC, n &gt; 9000 participants) study and the Rotterdam Study (n &gt; 5000), have shown that retinal diameter changes independently predict incident CV events and all-cause mortality. Recent UK Biobank (n &gt; 45,000) analyses further demonstrate incremental value in stroke prediction beyond traditional risk factors (AUC 0.739 to 0.752; p &lt; 0.001). Other retinal imaging modalities, such as optical coherence tomography angiography (OCTA) and adaptive optics (AO), provide complementary high-resolution structural data on capillary architecture and perfusion integrity.</div><div>The retinal vascular phenotype reflects both shared and disease-specific mechanisms of ED. Therefore, accurate interpretation of retinal biomarkers requires an understanding of the molecular pathways that shape ED across disease entities, thereby forming the conceptual foundation of oculomics. We synthesize current evidence linking systemic ED to retinal microvascular structure and function across major categories of inflammatory disease. We integrate findings from static and dynamic RVA, OCTA, and AO, discuss their mechanistic interpretation within the emerging framework of oculomics, and critically evaluate challenges for clinical translation. Finally, we outline how artificial intelligence (AI) may facilitate robust, scalable implementation of retinal biomarkers for risk stratification, disease monitoring, and outcome prediction. This review moves beyond modality-specific descriptions to propose a unified biological and translational framework for retinal biomarkers.</div></div>","PeriodicalId":21159,"journal":{"name":"Progress in Retinal and Eye Research","volume":"112 ","pages":"Article 101472"},"PeriodicalIF":14.7,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147842297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Are Müller glial cells gatekeepers of neuroprotection and regeneration in age-related macular degeneration? Unraveling their roles in pathophysiology and therapeutic innovation <s:1>神经胶质细胞是老年性黄斑变性神经保护和再生的守门人吗?揭示它们在病理生理学和治疗创新中的作用
IF 14.7 1区 医学
Progress in Retinal and Eye Research Pub Date : 2026-05-01 Epub Date: 2026-04-14 DOI: 10.1016/j.preteyeres.2026.101471
Kai-Yang Chen , Hoi-Chun Chan , Yih-Shiou Hwang , Wan-Wan Lin , Chi-Ming Chan
{"title":"Are Müller glial cells gatekeepers of neuroprotection and regeneration in age-related macular degeneration? Unraveling their roles in pathophysiology and therapeutic innovation","authors":"Kai-Yang Chen ,&nbsp;Hoi-Chun Chan ,&nbsp;Yih-Shiou Hwang ,&nbsp;Wan-Wan Lin ,&nbsp;Chi-Ming Chan","doi":"10.1016/j.preteyeres.2026.101471","DOIUrl":"10.1016/j.preteyeres.2026.101471","url":null,"abstract":"<div><div>Age-related macular degeneration (AMD) is traditionally conceptualized as a disorder of the retinal pigment epithelium (RPE)–photoreceptor axis; however, this paradigm incompletely explains early disease dynamics and therapeutic failure in geographic atrophy (GA). This review aims to reframe AMD progression through a Müller glial cell-centered framework that integrates cellular homeostasis, structural transitions, and stage-dependent therapeutic implications. Emerging transcriptomic, histologic, and functional evidence demonstrates that Müller glial cells actively participate in AMD pathobiology, including complement regulation, metabolic coupling, redox control, and inflammatory signaling. In early AMD, Müller glial cells exhibit adaptive responses that preserve retinal integrity despite increasing metabolic and extracellular stress. Progressive accumulation of basal laminar deposits and extracellular remodeling may impose diffusion constraints and inflammatory burden, thereby promoting glial reprogramming. A critical transition occurs with descent of the external limiting membrane (ELM), which corresponds to the loss of photoreceptor support, disruption of retinal compartmentalization, and onset of irreversible degeneration. Beyond this threshold, Müller glial cells undergo structural remodeling and contribute to the formation of subretinal glial membranes, reflecting a shift from homeostatic support to containment. This framework proposes a biologically testable staging axis from preserved Müller glial cell function to progressive dysfunction, aligning disease progression with therapeutic windows. Pre-ELM stages are characterized by retained plasticity and suitability for neuroprotective and metabolic interventions, whereas post-ELM stages require strategies focused on stabilization and limiting degeneration. Importantly, most current clinical trials do not explicitly incorporate Müller glial cell state or ELM integrity as stratification variables, potentially contributing to insensitive or diluted outcome assessment. In conclusion, Müller glial cells may function as central integrators of retinal homeostasis and disease progression in AMD. Integrating glial biology with structural biomarkers may enable stage-specific precision therapies and improve clinical trial design.</div></div>","PeriodicalId":21159,"journal":{"name":"Progress in Retinal and Eye Research","volume":"112 ","pages":"Article 101471"},"PeriodicalIF":14.7,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147681455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outer retinal tubulation associated with photoreceptor degeneration 视网膜外管化与光感受器变性有关
IF 14.7 1区 医学
Progress in Retinal and Eye Research Pub Date : 2026-03-01 Epub Date: 2026-01-16 DOI: 10.1016/j.preteyeres.2026.101435
Victor Lin , Winston Lee , Eugene Yu-Chuan Kang , Pei-Kang Liu , Nan-Kai Wang
{"title":"Outer retinal tubulation associated with photoreceptor degeneration","authors":"Victor Lin ,&nbsp;Winston Lee ,&nbsp;Eugene Yu-Chuan Kang ,&nbsp;Pei-Kang Liu ,&nbsp;Nan-Kai Wang","doi":"10.1016/j.preteyeres.2026.101435","DOIUrl":"10.1016/j.preteyeres.2026.101435","url":null,"abstract":"<div><div>Outer retinal tubulation (ORT) is a distinct structural manifestation of chronic photoreceptor degeneration, observed across a broad spectrum of retinal diseases. Initially described histologically as rosette-like formations, ORT has gained clinical relevance with the advent of high-resolution imaging modalities such as spectral-domain optical coherence tomography (SD-OCT) and adaptive optics scanning laser ophthalmoscopy (AO-SLO), which enable <em>in vivo</em> visualization of its tubular architecture. ORT arises from sustained photoreceptor and retinal pigment epithelium (RPE) injury, leading to the reorganization of surviving cones ensheathed by gliotic Müller cell processes. This review integrates historical, histological, and imaging data to elucidate ORT's cellular composition, formation mechanisms, and disease-specific patterns. We introduce a novel etiological classification of ORT, categorized as degenerative, fibrotic, or edematous ORT according to predominant pathogenic drivers, to facilitate cross-disease comparison and prognostic stratification. Clinically, ORT serves as a non-exudative biomarker of chronic retinal injury, aiding differential diagnosis and informing treatment strategies. In age-related macular degeneration, ORT is associated with subretinal fibrosis and poor visual outcomes; in geographic atrophy, it may signal slower lesion progression. In inherited retinal dystrophies, ORT reflects genotype-specific vulnerabilities and residual photoreceptor survival, with implications for therapeutic targeting. As imaging technologies advance, ORT offers promise as a structural marker of disease chronicity, photoreceptor resilience, and Müller cell plasticity, enhancing diagnostic precision and supporting its role as a meaningful endpoint in clinical trials.</div></div>","PeriodicalId":21159,"journal":{"name":"Progress in Retinal and Eye Research","volume":"111 ","pages":"Article 101435"},"PeriodicalIF":14.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145995272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Structural photoreceptor evaluation in age-related macular degeneration. A comprehensive review of methods and clinical significance 年龄相关性黄斑变性的结构光感受器评价。综合综述方法及临床意义。
IF 14.7 1区 医学
Progress in Retinal and Eye Research Pub Date : 2026-03-01 Epub Date: 2026-02-13 DOI: 10.1016/j.preteyeres.2026.101447
Lourdes Vidal-Oliver , Davide Garzone , Lukas Schloesser , Sarah Thiele , Maximilian Pfau , Wolf M. Harmening , Julius Ameln , Rosa Dolz-Marco , Nicolas Cuenca , Isabel Ortuño-Lizaran , Zhichao Wu , Robyn H. Guymer , Robert P. Finger
{"title":"Structural photoreceptor evaluation in age-related macular degeneration. A comprehensive review of methods and clinical significance","authors":"Lourdes Vidal-Oliver ,&nbsp;Davide Garzone ,&nbsp;Lukas Schloesser ,&nbsp;Sarah Thiele ,&nbsp;Maximilian Pfau ,&nbsp;Wolf M. Harmening ,&nbsp;Julius Ameln ,&nbsp;Rosa Dolz-Marco ,&nbsp;Nicolas Cuenca ,&nbsp;Isabel Ortuño-Lizaran ,&nbsp;Zhichao Wu ,&nbsp;Robyn H. Guymer ,&nbsp;Robert P. Finger","doi":"10.1016/j.preteyeres.2026.101447","DOIUrl":"10.1016/j.preteyeres.2026.101447","url":null,"abstract":"<div><div>Age-related macular degeneration (AMD) is a disease that primarily affects the outer retina, with progressive photoreceptor degeneration and atrophy of the retinal pigment epithelium (RPE). Advances in imaging now enable photoreceptor changes to be detected and quantified with unprecedented sensitivity, whereas comparable biomarkers of RPE dysfunction remain less developed. As such, photoreceptor-based biomarkers are increasingly considered potential surrogates for current clinical trial endpoints. This review examines the current imaging modalities—particularly optical coherence tomography (OCT) and modalities enhanced by adaptive optics (AO) —used to evaluate photoreceptor structure in AMD. We explore the intrinsic value of parameters such as outer nuclear layer thickness, external limiting membrane integrity, photoreceptor inner and outer segment thickness, ellipsoid zone (EZ) integrity, and EZ reflectivity on OCT, and cone density and regularity on AO imaging, highlighting their potential and limitations. While OCT-based metrics are the most accessible in clinical settings, their clinical utility is hampered by inconsistent segmentation protocols and methodological heterogeneity. AO imaging offers unmatched resolution but faces practical barriers to widespread adoption. The field is moving in a promising direction with emerging computational tools and artificial intelligence improving accuracy and scalability. However, progress is contingent on establishing consensus definitions, standardized acquisition and analysis protocols, and normative datasets. Future efforts should focus on translating high-resolution imaging into robust, reproducible biomarkers that can be widely adopted in both clinical practice and therapeutic development.</div></div>","PeriodicalId":21159,"journal":{"name":"Progress in Retinal and Eye Research","volume":"111 ","pages":"Article 101447"},"PeriodicalIF":14.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146202568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lens aging and disease: Molecular mechanisms, functional consequences, and pharmacological implications 晶状体老化和疾病:分子机制、功能后果和药理学意义
IF 14.7 1区 医学
Progress in Retinal and Eye Research Pub Date : 2026-03-01 Epub Date: 2026-02-10 DOI: 10.1016/j.preteyeres.2026.101446
Xingjun Fan , Vincent M. Monnier
{"title":"Lens aging and disease: Molecular mechanisms, functional consequences, and pharmacological implications","authors":"Xingjun Fan ,&nbsp;Vincent M. Monnier","doi":"10.1016/j.preteyeres.2026.101446","DOIUrl":"10.1016/j.preteyeres.2026.101446","url":null,"abstract":"<div><div>Age-related cataract (ARC) remains the leading cause of blindness worldwide, reflecting the progressive failure of lifelong mechanisms that preserve the transparency and refractive precision of the ocular lens. The lens is uniquely vulnerable to aging because its core fiber cells, crystallin proteins, and lipids persist for decades without turnover, relying on stable protein solubility, redox homeostasis, membrane integrity, and tightly coordinated epithelial renewal. With age, gradual biochemical and biomechanical shifts, including crystallin oxidation and truncation, deamidation and racemization, glycation, formation of disulfide and non-disulfide crosslinks, membrane remodeling, and stiffening of the lens nucleus, erode the structural and optical properties required for clear vision. Decline in glutathione (GSH) synthesis and redox-repair enzymes amplifies oxidative damage, while emerging evidence identifies ferroptosis, rather than apoptosis, as a dominant regulated cell-death pathway compromising lens epithelial cell survival in aging. In parallel, genome-wide association studies and exome sequencing have revealed a complex polygenic architecture for ARC, highlighting modifier genes that influence cytoskeletal resilience, protein stability, ion transport, and systemic metabolic signaling. Environmental exposures, including ultraviolet radiation, smoking, heat stress, and air pollution, interact with these genetic and biochemical pathways to accelerate opacity formation. This review integrates recent advances in lens biology, proteomics, redox regulation, lipid and membrane biophysics, mechanobiology, and cell death signaling to provide a cohesive framework for understanding how age-related changes converge to produce cataract. We also outline emerging therapeutic strategies that target redox buffering, crystallin stability, epithelial survival pathways, and biomechanical properties of the aging lens.</div></div>","PeriodicalId":21159,"journal":{"name":"Progress in Retinal and Eye Research","volume":"111 ","pages":"Article 101446"},"PeriodicalIF":14.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146152643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书